DYADIC INTERNATIONAL INC Proceeds from Sale and Maturity of Held-to-maturity Securities
DYADIC INTERNATIONAL INC (DYAI) reported Proceeds from Sale and Maturity of Held-to-maturity Securities of $2.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities · last filed 2026-08-12
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-06-30 was $370.00K, a 82.71% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2026-03-31 was $1.83M, a 5.58% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-12-31 was $1.33M, a 49.54% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2025-09-30 was $624.01K, a 49.06% decline year-over-year.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for fiscal 2025 was $6.03M, a 11.62% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for fiscal 2024 was $5.41M, a 40.91% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for fiscal 2023 was $9.15M, a 21.97% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC proceeds from sale and maturity of held-to-maturity securities for fiscal 2022 was $7.50M, a 49.66% decline from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month as first filed | Proceeds from Sale and Maturity of Held-to-maturity Securities 6 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 9 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.20M 10-Q · filed 2026-08-12 | $3.53M derived: sum of 3 quarters · filed 2026-08-12 | $4.16M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $1.83M 10-Q · filed 2026-05-13 | $3.16M derived: sum of 2 quarters · filed 2026-05-13 | $3.79M derived: sum of 3 quarters · filed 2026-05-13 | $5.93M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.95M derived: sum of 2 quarters · filed 2026-03-25 | $4.09M derived: sum of 3 quarters · filed 2026-08-12 | $6.03M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $624.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.76M derived: sum of 2 quarters · filed 2026-08-12 | $4.70M 10-Q · filed 2025-11-12 | $7.34M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.08M 10-Q · filed 2026-08-12 | $6.72M derived: sum of 3 quarters · filed 2026-08-12 | $7.94M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $1.94M 10-Q · filed 2026-05-13 | $4.58M derived: sum of 2 quarters · filed 2026-05-13 | $5.80M derived: sum of 3 quarters · filed 2026-05-13 | $6.45M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $3.86M derived: sum of 2 quarters · filed 2026-03-25 | $4.51M derived: sum of 3 quarters · filed 2026-03-25 | $5.41M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.87M derived: sum of 2 quarters · filed 2025-11-12 | $2.77M 10-Q · filed 2025-11-12 | $3.55M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.55M 10-Q · filed 2025-08-13 | $2.32M derived: sum of 3 quarters · filed 2025-08-13 | $6.13M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-14 | $1.68M derived: sum of 2 quarters · filed 2025-05-14 | $5.49M derived: sum of 3 quarters · filed 2025-05-14 | $7.83M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $4.58M derived: sum of 2 quarters · filed 2025-03-26 | $6.93M derived: sum of 3 quarters · filed 2025-03-26 | $9.15M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.16M derived: sum of 2 quarters · filed 2024-11-12 | $8.37M 10-Q · filed 2024-11-12 | $10.37M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.56M 10-Q · filed 2024-08-13 | $6.56M derived: sum of 3 quarters · filed 2024-08-13 | $7.56M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $2.21M 10-Q · filed 2024-05-14 | $4.21M derived: sum of 2 quarters · filed 2024-05-14 | $5.21M derived: sum of 3 quarters · filed 2024-05-14 | $5.21M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.00M derived: sum of 2 quarters · filed 2024-03-28 | $3.00M derived: sum of 3 quarters · filed 2024-03-28 | $7.50M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.00M derived: sum of 2 quarters · filed 2023-11-08 | $5.50M 10-Q · filed 2023-11-08 | $10.00M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.50M 10-Q · filed 2023-08-09 | $9.00M derived: sum of 3 quarters · filed 2023-08-09 | $11.40M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $4.50M 10-Q · filed 2023-05-10 | $4.50B 10-Q · filed 2022-05-12 | $9.00M derived: sum of 2 quarters · filed 2023-05-10 | $11.40M derived: sum of 3 quarters · filed 2023-05-10 | -$5.48B derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $6.90M derived: sum of 2 quarters · filed 2023-03-29 | -$5.49B derived: sum of 3 quarters · filed 2023-03-29 | $14.90M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$5.49B derived: sum of 2 quarters · filed 2022-11-10 | $10.40M 10-Q · filed 2022-11-10 | $13.40M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$5.49B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $8.00M 10-Q · filed 2022-08-10 | $11.00M derived: sum of 3 quarters · filed 2022-08-10 | $22.46M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $5.50B 10-Q · filed 2022-05-12 | $5.50M 10-Q · filed 2021-05-13 | $5.50B derived: sum of 2 quarters · filed 2022-05-12 | $5.51B derived: sum of 3 quarters · filed 2022-05-12 | $5.53B derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $14.46M derived: sum of 2 quarters · filed 2022-03-29 | $26.41M derived: sum of 3 quarters · filed 2022-03-29 | $39.76M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $11.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $23.41M derived: sum of 2 quarters · filed 2021-11-10 | $36.76M 10-Q · filed 2021-11-10 | $48.13M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $11.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $25.30M 10-Q · filed 2021-08-12 | $36.67M derived: sum of 3 quarters · filed 2021-08-12 | $51.95M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $13.35M 10-Q · filed 2021-05-13 | $24.72M derived: sum of 2 quarters · filed 2021-05-13 | $40.00M derived: sum of 3 quarters · filed 2021-05-13 | $52.48M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $11.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $26.65M derived: sum of 2 quarters · filed 2021-03-30 | $39.13M derived: sum of 3 quarters · filed 2021-03-30 | $55.32M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $15.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $27.76M derived: sum of 2 quarters · filed 2020-11-12 | $43.95M 10-Q · filed 2020-11-12 | $56.28M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $12.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $28.68M 10-Q · filed 2020-08-13 | $41.00M derived: sum of 3 quarters · filed 2020-08-13 | $51.23M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $16.20M 10-Q · filed 2020-05-14 | $28.52M derived: sum of 2 quarters · filed 2020-05-14 | $38.75M derived: sum of 3 quarters · filed 2020-05-14 | $51.62M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $22.56M derived: sum of 2 quarters · filed 2020-03-30 | $35.42M derived: sum of 3 quarters · filed 2020-03-30 | $53.06M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $23.10M derived: sum of 2 quarters · filed 2019-11-13 | $40.74M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $12.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $30.51M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $17.64M 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $50.65M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |